Low circulating adiponectin levels are associated with insulin resistance in non-obese peritoneal dialysis patients

Endocrine Journal

Volumn 59, Issue 8, 2012, Pages 685-695

  Yoo, Dong Eun ^a   Lee, Mi Jung ^a   Oh, Hyung Jung ^a   Kim, Seung Jun ^a   Shin, Dong Ho ^a   Yoo, Tae Hyun ^a   Kang, Shin Wook ^a,b   Choi, Kyu Hun ^a   Han, Dae Suk ^a   Han, Seung Hyeok ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Adipokine; Chronic inflammation; Insulin resistance; Non obese; Peritoneal dialysis

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LEPTIN; RESISTIN; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADULT; AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; LEPTIN; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PERITONEAL DIALYSIS; RESISTIN;

EID: 84867909962     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0032     Document Type: Article

References (48)

1. Collins AJ, Li S, Ma JZ, Herzog C (2001) Cardiovascular disease in end-stage renal disease patients. Am J Kidney Dis 38:S26-29.
2. Zoccali C (2000) Cardiovascular risk in uraemic patients-is it fully explained by classical risk factors? Nephrol Dial Transplant 15:454-457.
3. Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607.
4. Sethi JK, Vidal-Puig AJ (2007) Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res 48:1253-1262.
5. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808.
6. Guarnieri G, Faccini L, Lipartiti T, Ranieri F, Spangaro F, Giuntini D, Toigo G, Dardi F, Berquier-Vidali F, Raimondi A (1980) Simple methods for nutritional assessment in hemodialyzed patients. Am J Clin Nutr 33:1598-1607.
7. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y (2002) Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13:1894-1900.
8. Guarnieri G, Zanetti M, Vinci P, Cattin MR, Barazzoni R (2009) Insulin resistance in chronic uremia. J Ren Nutr 19:20-24.
9. Taskapan MC, Taskapan H, Sahin I, Keskin L, Atmaca H, Ozyalin F (2007) Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality. Ren Fail 29:147-154.
10. Lin SH, Lin YF, Kuo SW, Hsu YJ, Hung YJ (2003) Rosiglitazone improves glucose metabolism in nondiabetic uremic patients on CAPD. Am J Kidney Dis 42:774-780.
11. Nurmi J, Korkeila M, Honkanen E, Lindgren L, Castren M (2010) Effect of peritoneal dialysis on abdominal circumference. Perit Dial Int 30:215-217.
12. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, Kim DY, Kwon HS, Kim SR, Lee CB, Oh SJ, Park CY, Yoo HJ (2007) Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 75:72-80.
13. Deurenberg-Yap M, Chew SK, Deurenberg P (2002) Elevated body fat percentage and cardiovascular risks at low body mass index levels among Singaporean Chinese, Malays and Indians. Obes Rev 3:209-215.
14. Ko GT, Chan JC, Cockram CS, Woo J (1999) Prediction of hypertension, diabetes, dyslipidaemia or albuminu ria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord 23:1136-1142.
15. Ko GT, Tang J, Chan JC, Sung R, Wu MM, Wai HP, Chen R (2001) Lower BMI cut-off value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance. Br J Nutr 85:239-242.
16. Yajnik CS, Yudkin JS (2004) The Y-Y paradox. Lancet 363:163.
17. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, Jeejeebhoy KN (1987) What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 11:8-13.
18. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Jr., Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419.
20. Watson PE, Watson ID, Batt RD (1980) Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 33:27-39.
21. Bodnar DM, Busch S, Fuchs J, Piedmonte M, Schreiber M (1993) Estimating glucose absorption in peritoneal dialysis using peritoneal equilibration tests. Adv Perit Dial 9:114-118.
22. Han SH, Choi SH, Cho BJ, Lee Y, Lim S, Park YJ, Moon MK, Lee HK, Kang SW, Han DS, Kim YB, Jang HC, Park KS (2010) Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis. Metabolism 59:1656-1662.
23. Enriori PJ, Evans AE, Sinnayah P, Cowley MA (2006) Leptin resistance and obesity. Obesity (Silver Spring) 14 Suppl 5:254S-258S.
24. Kieffer TJ, Heller RS, Leech CA, Holz GG, Habener JF (1997) Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells. Diabetes 46:1087-1093.
25. Stenvinkel P, Heimburger O, Lonnqvist F (1997) Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transplant 12:1321-1325.
26. Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26:439-451.
27. Kataoka H, Sharma K (2006) Renal handling of adipokines. Contrib Nephrol 151:91-105.
28. Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J (2004) Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 65:1009-1016.
29. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y (2002) Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13:134-141.
30. Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD (2004) Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis 43:1047-1055.
31. Rao M, Li L, Tighiouart H, Jaber BL, Pereira BJ, Balakrishnan VS (2008) Plasma adiponectin levels and clinical outcomes among haemodialysis patients. Nephrol Dial Transplant 23:2619-2628.
32. Pellme F, Smith U, Funahashi T, Matsuzawa Y, Brekke H, Wiklund O, Taskinen MR, Jansson PA (2003) Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes 52:1182-1186.
33. Tai ES, Tan ML, Stevens RD, Low YL, Muehlbauer MJ, Goh DL, Ilkayeva OR, Wenner BR, Bain JR, Lee JJ, Lim SC, Khoo CM, Shah SH, Newgard CB (2010) Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia 53:757-767.
34. Taniguchi A, Fukushima M, Ohya M, Nakai Y, Yoshii S, Nagasaka S, Matsumoto K, Taki Y, Kuroe A, Nishimura F, Seino Y (2006) Interleukin 6, adiponectin, leptin, and insulin resistance in nonobese Japanese type 2 diabetic patients. Metabolism 55:258-262.
35. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T (2006) Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 29:1357-1362.
36. Bluher M, Brennan AM, Kelesidis T, Kratzsch J, Fasshauer M, Kralisch S, Williams CJ, Mantzoros CS (2007) Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care 30:280-285.
37. Zoccali C, Tripepi G, Cambareri F, Catalano F, Finocchiaro P, Cutrupi S, Pizzini P, Testa A, Spoto B, Panuccio V, Enia G, Mallamaci F (2005) Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients. J Ren Nutr 15:125-130.
38. Merabet E, Dagogo-Jack S, Coyne DW, Klein S, Santiago JV, Hmiel SP, Landt M (1997) Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab 82:847-850.
39. Diez JJ, Iglesias P, Fernandez-Reyes MJ, Aguilera A, Bajo MA, Alvarez-Fidalgo P, Codoceo R, Selgas R (2005) Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease. Clin Endocrinol (Oxf) 62:242-249.
40. Axelsson J, Bergsten A, Qureshi AR, Heimburger O, Barany P, Lonnqvist F, Lindholm B, Nordfors L, Alvestrand A, Stenvinkel P (2006) Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 69:596-604.
41. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (2001) The hormone resistin links obesity to diabetes. Nature 409:307-312.
42. Kielstein JT, Becker B, Graf S, Brabant G, Haller H, Fliser D (2003) Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am J Kidney Dis 42:62-66.
43. Ramos LF, Shintani A, Ikizler TA, Himmelfarb J (2008) Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol 19:593-599.
44. Nakanishi N, Shiraishi T, Wada M (2005) Association between C-reactive protein and insulin resistance in a Japanese population: the Minoh Study. Intern Med 44:542-547.
45. Brame LA, Considine RV, Yamauchi M, Baron AD, Mather KJ (2005) Insulin and endothelin in the acute regulation of adiponectin in vivo in humans. Obes Res 13:582-588.
46. Mohlig M, Wegewitz U, Osterhoff M, Isken F, Ristow M, Pfeiffer AF, Spranger J (2002) Insulin decreases human adiponectin plasma levels. Horm Metab Res 34:655-658.
47. Shoji T, Emoto M, Nishizawa Y (2001) HOMA index to assess insulin resistance in renal failure patients. Nephron 89:348-349.
48. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, Lupien PJ (1994) Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73:460-468.